Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Cardiovascular risk assessment in children with chronic kidney disease.

Shroff R, Dégi A, Kerti A, Kis E, Cseprekál O, Tory K, Szabó AJ, Reusz GS.

Pediatr Nephrol. 2013 Jun;28(6):875-84. doi: 10.1007/s00467-012-2325-3. Epub 2012 Oct 16. Review.

PMID:
23070276
2.

Pediatric CKD and cardiovascular disease.

Safder O, Al sharif S, Kari JA.

Cardiovasc Hematol Disord Drug Targets. 2014;14(3):177-84. Review.

PMID:
24720458
3.

Left ventricular remodeling and arterial remodeling in patients with chronic kidney disease stage 1-3.

Pluta A, Stróżecki P, Krintus M, Odrowąż-Sypniewska G, Manitius J.

Ren Fail. 2015 Aug;37(7):1105-10. doi: 10.3109/0886022X.2015.1061669. Epub 2015 Jul 9.

PMID:
26156686
4.

The Addition of Vascular Calcification Scores to Traditional Risk Factors Improves Cardiovascular Risk Assessment in Patients with Chronic Kidney Disease.

Liabeuf S, Desjardins L, Diouf M, Temmar M, Renard C, Choukroun G, Massy ZA.

PLoS One. 2015 Jul 16;10(7):e0131707. doi: 10.1371/journal.pone.0131707. eCollection 2015.

5.

Peripheral and central arterial pressure and its relationship to vascular target organ damage in carotid artery, retina and arterial stiffness. Development and validation of a tool. The Vaso risk study.

Garcia-Ortiz L, Ramos-Delgado E, Recio-Rodriguez JI, Agudo-Conde C, Martínez-Salgado C, Patino-Alonso MC, Rodriguez-Sanchez E, Gomez-Marcos MA; Vaso risk group.

BMC Public Health. 2011 Apr 27;11:266. doi: 10.1186/1471-2458-11-266.

6.

Cardiovascular alterations do exist in children with stage-2 chronic kidney disease.

Taşdemir M, Eroğlu AG, Canpolat N, Konukoğlu D, Ağbaş A, Sevim MD, Çalışkan S, Sever L.

Clin Exp Nephrol. 2016 Dec;20(6):926-933. Epub 2016 Jan 28.

PMID:
26822545
7.

Serum magnesium level and vascular stiffness in children with chronic kidney disease on regular hemodialysis.

Zaher MM, Abdel-Salam M, Abdel-Salam R, Sabour R, Morsy AA, Gamal D.

Saudi J Kidney Dis Transpl. 2016 Mar;27(2):233-40. doi: 10.4103/1319-2442.178205.

8.

Soluble TWEAK and Major Adverse Cardiovascular Events in Patients with CKD.

Fernández-Laso V, Sastre C, Valdivielso JM, Betriu A, Fernández E, Egido J, Martín-Ventura JL, Blanco-Colio LM.

Clin J Am Soc Nephrol. 2016 Mar 7;11(3):413-22. doi: 10.2215/CJN.07900715. Epub 2016 Jan 4.

9.

[Relationship of arterial wall parameters to cardiovascular risk factors and cardiovascular risk assessed by SCORE system].

Kovaite M, Petrulioniene Z, Ryliskyte L, Badariene J, Cypiene A, Dzenkeviciūte V, Laucevicius A.

Medicina (Kaunas). 2007;43(7):529-41. Lithuanian.

10.

Radiographic assessment of vascular calcification, aortic pulse wave velocity, ankle-brachial index and fibroblast growth factor-23 in chronic hemodialysis patients.

Breznik S, Ekart R, Hren M, Rupreht M, Balon BP.

Ther Apher Dial. 2013 Aug;17(4):378-83. doi: 10.1111/1744-9987.12082.

PMID:
23931875
11.

Assessment of arterial stiffness in patients with CKD stage 5 when initiating chronic hemodialysis for vascular access and for preventing cardiovascular events.

Mateş A, Golea O, Tudoran M, Tudoran C, Pescariu S, Velciov S.

Rom J Intern Med. 2012 Jul-Sep;50(3):225-31.

PMID:
23330290
12.

Ambulatory arterial stiffness in chronic kidney disease: a methodological review.

László A, Reusz G, Nemcsik J.

Hypertens Res. 2016 Apr;39(4):192-8. doi: 10.1038/hr.2015.137. Epub 2015 Dec 3. Review.

PMID:
26631849
13.

Large artery stiffening and remodeling are independently associated with all-cause mortality and cardiovascular events in chronic kidney disease.

Karras A, Haymann JP, Bozec E, Metzger M, Jacquot C, Maruani G, Houillier P, Froissart M, Stengel B, Guardiola P, Laurent S, Boutouyrie P, Briet M; Nephro Test Study Group.

Hypertension. 2012 Dec;60(6):1451-7. doi: 10.1161/HYPERTENSIONAHA.112.197210. Epub 2012 Oct 22.

14.
15.

Effect of Moderate Aerobic Exercise Training on Endothelial Function and Arterial Stiffness in CKD Stages 3-4: A Randomized Controlled Trial.

Van Craenenbroeck AH, Van Craenenbroeck EM, Van Ackeren K, Vrints CJ, Conraads VM, Verpooten GA, Kouidi E, Couttenye MM.

Am J Kidney Dis. 2015 Aug;66(2):285-96. doi: 10.1053/j.ajkd.2015.03.015. Epub 2015 May 8.

PMID:
25960303
16.

Low urinary citrulline/arginine ratio associated with blood pressure abnormalities and arterial stiffness in childhood chronic kidney disease.

Lin IC, Hsu CN, Lo MH, Chien SJ, Tain YL.

J Am Soc Hypertens. 2016 Feb;10(2):115-23. doi: 10.1016/j.jash.2015.11.008. Epub 2015 Nov 22.

PMID:
26712087
17.

Cardiovascular risk in chronic kidney disease patients: intima-media thickness predicts the incidence and severity of histologically assessed medial calcification in radial arteries.

Janda K, Krzanowski M, Gajda M, Dumnicka P, Fedak D, Lis GJ, Jaśkowski P, Pietrzycka A, Litwin JA, Sułowicz W.

BMC Nephrol. 2015 Jun 3;16:78. doi: 10.1186/s12882-015-0067-8.

18.

Correlations of Plasma Desphosphorylated Uncarboxylated Matrix Gla Protein with Vascular Calcification and Vascular Stiffness in Chronic Kidney Disease.

Thamratnopkoon S, Susantitaphong P, Tumkosit M, Katavetin P, Tiranathanagul K, Praditpornsilpa K, Eiam-Ong S.

Nephron. 2017;135(3):167-172. doi: 10.1159/000453368. Epub 2016 Dec 13.

PMID:
27951533
19.

Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients.

Liabeuf S, Lenglet A, Desjardins L, Neirynck N, Glorieux G, Lemke HD, Vanholder R, Diouf M, Choukroun G, Massy ZA; European Uremic Toxin Work Group (EUTox).

Kidney Int. 2012 Dec;82(12):1297-303. doi: 10.1038/ki.2012.301. Epub 2012 Aug 15.

20.

A decreased level of serum soluble Klotho is an independent biomarker associated with arterial stiffness in patients with chronic kidney disease.

Kitagawa M, Sugiyama H, Morinaga H, Inoue T, Takiue K, Ogawa A, Yamanari T, Kikumoto Y, Uchida HA, Kitamura S, Maeshima Y, Nakamura K, Ito H, Makino H.

PLoS One. 2013;8(2):e56695. doi: 10.1371/journal.pone.0056695. Epub 2013 Feb 19.

Supplemental Content

Support Center